>
UAE's OPEC exit hands Asia a petroyuan moment
Iran President Pezeshkian weighs Araghchi ouster for 'defying orders' in US talks
Stephen Miller: This scandal will 'rock the CORE' of politics
For decades, many parts of Iran have struggled with severe drought.
"This is the first synthetic species," microbiologist J. Craig Venter told 60 Minutes'
Humanoid robots are hitting the factories at an increasing pace
Microsoft's $400 Billion Mistake Is Now a $200 Phone With Zero Tracking
Turn Sand to Stone With Vinegar. Stronger Than Steel. Hidden Since 1627
This is a bioprinter printing with living human cells in real time
The remarkable initiative is called The Uncensored Library,...
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
Mining companies are using cosmic rays to find critical minerals

An ancient Greek drug derived from the saffron plant could improve the treatment of people with severe COVID-19 and reduce the COVID mortality rate by as much as 50%, according to a report published earlier this month in the European Journal of Internal Medicine by an Israeli researcher from the Hebrew University of Jerusalem and Hadassah Medical School.
The drug, colchicine, dates back thousands of years to ancient Egypt, where it was known for its special healing properties. It is one of a few medicines that survived until modern times. Most recently, it has been used to treat and prevent inflammation caused by gout that can lead to painful arthritis and Familial Mediterranean Fever (FMF), which is common among Jewish people of North African descent.